642 related articles for article (PubMed ID: 27974562)
1.
Caine EA; Osorio JE
J Virol; 2017 Mar; 91(5):. PubMed ID: 27974562
[TBL] [Abstract][Full Text] [Related]
2. A Single Mutation in the VP1 of Enterovirus 71 Is Responsible for Increased Virulence and Neurotropism in Adult Interferon-Deficient Mice.
Caine EA; Moncla LH; Ronderos MD; Friedrich TC; Osorio JE
J Virol; 2016 Oct; 90(19):8592-604. PubMed ID: 27440896
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE
Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938
[TBL] [Abstract][Full Text] [Related]
4.
Meng T; Jia Q; Wong SM; Chua KB
J Virol; 2019 Sep; 93(17):. PubMed ID: 31167919
[TBL] [Abstract][Full Text] [Related]
5. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
J Virol; 2017 May; 91(9):. PubMed ID: 28250116
[TBL] [Abstract][Full Text] [Related]
6. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection.
Khong WX; Yan B; Yeo H; Tan EL; Lee JJ; Ng JK; Chow VT; Alonso S
J Virol; 2012 Feb; 86(4):2121-31. PubMed ID: 22130542
[TBL] [Abstract][Full Text] [Related]
7. Pathogenicity and landscape of differential gene expression in mice orally infected with clinical coxsackievirus A6 (CA6).
Zhang L; Peng W; Wu J; Wei X; Rong N; Zhang G; Yang H; Ding X; Zhao B; Liu J
J Virol; 2024 Feb; 98(2):e0135823. PubMed ID: 38226810
[TBL] [Abstract][Full Text] [Related]
8. Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy.
Wang H; Guo T; Yang Y; Yu L; Pan X; Li Y
Front Cell Infect Microbiol; 2019; 9():277. PubMed ID: 31448243
[TBL] [Abstract][Full Text] [Related]
9. Association of viral replication capacity with the pathogenicity of enterovirus 71.
Sun LL; Wang JK; Cui XQ; Hao SB; Li J; Zhao L; Yuan XJ; Wen HL; Yu XJ; Wang ZY
Virus Res; 2014 Aug; 189():1-7. PubMed ID: 24792876
[TBL] [Abstract][Full Text] [Related]
10. Enterovirus A71 Induces Neurological Diseases and Dynamic Variants in Oral Infection of Human SCARB2-Transgenic Weaned Mice.
Lin JY; Weng KF; Chang CK; Gong YN; Huang GJ; Lee HL; Chen YC; Huang CC; Lu JY; Huang PN; Chiang HJ; Chen CM; Shih SR
J Virol; 2021 Oct; 95(21):e0089721. PubMed ID: 34379497
[TBL] [Abstract][Full Text] [Related]
11. A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice.
Wang W; Duo J; Liu J; Ma C; Zhang L; Wei Q; Qin C
Microbes Infect; 2011 Sep; 13(10):862-70. PubMed ID: 21612764
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin Facilitates Enterovirus 71 Infection by Mediating Viral Entry.
He QQ; Ren S; Xia ZC; Cheng ZK; Peng NF; Zhu Y
J Virol; 2018 May; 92(9):. PubMed ID: 29467312
[TBL] [Abstract][Full Text] [Related]
13. Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71.
Yamayoshi S; Iizuka S; Yamashita T; Minagawa H; Mizuta K; Okamoto M; Nishimura H; Sanjoh K; Katsushima N; Itagaki T; Nagai Y; Fujii K; Koike S
J Virol; 2012 May; 86(10):5686-96. PubMed ID: 22438546
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of enterovirus 71 to adult interferon deficient mice.
Caine EA; Partidos CD; Santangelo JD; Osorio JE
PLoS One; 2013; 8(3):e59501. PubMed ID: 23527208
[TBL] [Abstract][Full Text] [Related]
15. Immunological evaluation and comparison of different EV71 vaccine candidates.
Chou AH; Liu CC; Chang JY; Lien SP; Guo MS; Tasi HP; Hsiao KN; Liu SJ; Sia C; Wu SC; Lee MS; Hsiao CH; Wang JR; Chow YH; Chong P
Clin Dev Immunol; 2012; 2012():831282. PubMed ID: 23008736
[TBL] [Abstract][Full Text] [Related]
16. A Novel Murine Model Expressing a Chimeric mSCARB2/hSCARB2 Receptor Is Highly Susceptible to Oral Infection with Clinical Isolates of Enterovirus 71.
Yang CH; Liang CT; Jiang ST; Chen KH; Yang CC; Cheng ML; Ho HY
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894476
[TBL] [Abstract][Full Text] [Related]
17. Antiviral screen identifies EV71 inhibitors and reveals camptothecin-target, DNA topoisomerase 1 as a novel EV71 host factor.
Wu KX; Chu JJ
Antiviral Res; 2017 Jul; 143():122-133. PubMed ID: 28427827
[TBL] [Abstract][Full Text] [Related]
18. Dissecting complicated viral spreading of enterovirus 71 using in situ bioorthogonal fluorescent labeling.
Pan H; Yao X; Chen W; Wang F; He H; Liu L; He Y; Chen J; Jiang P; Zhang R; Ma Y; Cai L
Biomaterials; 2018 Oct; 181():199-209. PubMed ID: 30086449
[TBL] [Abstract][Full Text] [Related]
19. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
